After years of effort, scientists and families of young patients with a rare genetic condition are facing the prospect of three companies launching clinical trials to develop therapies. But can the community support more than one trial at the same time?
from WSJ.com: US Business http://ift.tt/1PmD59X
via IFTTT
No comments:
Post a Comment